<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 3 Endpoints</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>$(document).ready(function(){
    if (typeof $('[data-toggle="tooltip"]').tooltip === 'function') {
        $('[data-toggle="tooltip"]').tooltip();
    }
    if ($('[data-toggle="popover"]').popover === 'function') {
        $('[data-toggle="popover"]').popover();
    }
});
</script>
<style type="text/css">
.lightable-minimal {
border-collapse: separate;
border-spacing: 16px 1px;
width: 100%;
margin-bottom: 10px;
}
.lightable-minimal td {
margin-left: 5px;
margin-right: 5px;
}
.lightable-minimal th {
margin-left: 5px;
margin-right: 5px;
}
.lightable-minimal thead tr:last-child th {
border-bottom: 2px solid #00000050;
empty-cells: hide;
}
.lightable-minimal tbody tr:first-child td {
padding-top: 0.5em;
}
.lightable-minimal.lightable-hover tbody tr:hover {
background-color: #f5f5f5;
}
.lightable-minimal.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-classic {
border-top: 0.16em solid #111111;
border-bottom: 0.16em solid #111111;
width: 100%;
margin-bottom: 10px;
margin: 10px 5px;
}
.lightable-classic tfoot tr td {
border: 0;
}
.lightable-classic tfoot tr:first-child td {
border-top: 0.14em solid #111111;
}
.lightable-classic caption {
color: #222222;
}
.lightable-classic td {
padding-left: 5px;
padding-right: 5px;
color: #222222;
}
.lightable-classic th {
padding-left: 5px;
padding-right: 5px;
font-weight: normal;
color: #222222;
}
.lightable-classic thead tr:last-child th {
border-bottom: 0.10em solid #111111;
}
.lightable-classic.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-classic.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-classic-2 {
border-top: 3px double #111111;
border-bottom: 3px double #111111;
width: 100%;
margin-bottom: 10px;
}
.lightable-classic-2 tfoot tr td {
border: 0;
}
.lightable-classic-2 tfoot tr:first-child td {
border-top: 3px double #111111;
}
.lightable-classic-2 caption {
color: #222222;
}
.lightable-classic-2 td {
padding-left: 5px;
padding-right: 5px;
color: #222222;
}
.lightable-classic-2 th {
padding-left: 5px;
padding-right: 5px;
font-weight: normal;
color: #222222;
}
.lightable-classic-2 tbody tr:last-child td {
border-bottom: 3px double #111111;
}
.lightable-classic-2 thead tr:last-child th {
border-bottom: 1px solid #111111;
}
.lightable-classic-2.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-classic-2.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-material {
min-width: 100%;
white-space: nowrap;
table-layout: fixed;
font-family: Roboto, sans-serif;
border: 1px solid #EEE;
border-collapse: collapse;
margin-bottom: 10px;
}
.lightable-material tfoot tr td {
border: 0;
}
.lightable-material tfoot tr:first-child td {
border-top: 1px solid #EEE;
}
.lightable-material th {
height: 56px;
padding-left: 16px;
padding-right: 16px;
}
.lightable-material td {
height: 52px;
padding-left: 16px;
padding-right: 16px;
border-top: 1px solid #eeeeee;
}
.lightable-material.lightable-hover tbody tr:hover {
background-color: #f5f5f5;
}
.lightable-material.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-material.lightable-striped tbody td {
border: 0;
}
.lightable-material.lightable-striped thead tr:last-child th {
border-bottom: 1px solid #ddd;
}
.lightable-material-dark {
min-width: 100%;
white-space: nowrap;
table-layout: fixed;
font-family: Roboto, sans-serif;
border: 1px solid #FFFFFF12;
border-collapse: collapse;
margin-bottom: 10px;
background-color: #363640;
}
.lightable-material-dark tfoot tr td {
border: 0;
}
.lightable-material-dark tfoot tr:first-child td {
border-top: 1px solid #FFFFFF12;
}
.lightable-material-dark th {
height: 56px;
padding-left: 16px;
padding-right: 16px;
color: #FFFFFF60;
}
.lightable-material-dark td {
height: 52px;
padding-left: 16px;
padding-right: 16px;
color: #FFFFFF;
border-top: 1px solid #FFFFFF12;
}
.lightable-material-dark.lightable-hover tbody tr:hover {
background-color: #FFFFFF12;
}
.lightable-material-dark.lightable-striped tbody tr:nth-child(even) {
background-color: #FFFFFF12;
}
.lightable-material-dark.lightable-striped tbody td {
border: 0;
}
.lightable-material-dark.lightable-striped thead tr:last-child th {
border-bottom: 1px solid #FFFFFF12;
}
.lightable-paper {
width: 100%;
margin-bottom: 10px;
color: #444;
}
.lightable-paper tfoot tr td {
border: 0;
}
.lightable-paper tfoot tr:first-child td {
border-top: 1px solid #00000020;
}
.lightable-paper thead tr:last-child th {
color: #666;
vertical-align: bottom;
border-bottom: 1px solid #00000020;
line-height: 1.15em;
padding: 10px 5px;
}
.lightable-paper td {
vertical-align: middle;
border-bottom: 1px solid #00000010;
line-height: 1.15em;
padding: 7px 5px;
}
.lightable-paper.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-paper.lightable-striped tbody tr:nth-child(even) {
background-color: #00000008;
}
.lightable-paper.lightable-striped tbody td {
border: 0;
}
</style>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { display: inline-block; text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">

div.csl-bib-body { }
div.csl-entry {
clear: both;
margin-bottom: 0em;
}
.hanging div.csl-entry {
margin-left:2em;
text-indent:-2em;
}
div.csl-left-margin {
min-width:2em;
float:left;
}
div.csl-right-inline {
margin-left:2em;
padding-left:1em;
}
div.csl-indent {
margin-left: 2em;
}
</style>

<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Bioequivalence Tests for Parallel Trial
Designs: 3 Arms, 3 Endpoints</h1>



<p>In the <code>SimTOST</code> R package, which is specifically designed
for sample size estimation for bioequivalence studies, hypothesis
testing is based on the Two One-Sided Tests (TOST) procedure. <span class="citation">(<a href="#ref-sozu_sample_2015">Sozu et al.
2015</a>)</span> In TOST, the equivalence test is framed as a comparison
between the the null hypothesis of ‘new product is worse by a clinically
relevant quantity’ and the alternative hypothesis of ‘difference between
products is too small to be clinically relevant’. This vignette focuses
on a parallel design, with 3 arms/treatments and 3 primary
endpoints.</p>
<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>Similar to the example presented in <a href="sampleSize_parallel_2A3E.html">Bioequivalence Tests for Parallel
Trial Designs: 2 Arms, 3 Endpoints</a>, where equivalence across
multiple endpoints was assessed, this vignette extends the framework to
trials involving two reference products. This scenario arises when
regulators from different regions require comparisons with their locally
sourced reference biosimilars.</p>
<p>In many studies, the aim is to evaluate equivalence across multiple
primary variables. For example, the European Medicines Agency (EMA)
recommends demonstrating equivalence for both the Area Under the Curve
(AUC) and the maximum concentration (Cmax) when endpoints. In this
scenario, we additionally evaluate equivalence across three treatment
arms, including a test biosimilar and two reference products, each
sourced from a different regulatory region.</p>
<p>This vignette demonstrates advanced techniques for calculating sample
size in such trials, in which multiple endpoints and multiple reference
products are considered. As an illustrative example, we use data from
the phase 1 trial <a href="https://clinicaltrials.gov/study/NCT01922336#study-overview">NCT01922336</a>,
which assessed pharmacokinetic (PK) endpoints following a single dose of
SB2, its EU-sourced reference product (EU-INF), and its US-sourced
reference product (US-INF) <span class="citation">(<a href="#ref-shin_randomized_2015">Shin et al. 2015</a>)</span>.</p>
<table class="table table-striped" style="margin-left: auto; margin-right: auto;">
<caption>
Primary PK measures between test and reference product. Data represent
arithmetic mean +- standard deviation.
</caption>
<thead>
<tr>
<th style="text-align:left;">
PK measure
</th>
<th style="text-align:left;">
SB2
</th>
<th style="text-align:left;">
EU-INF
</th>
<th style="text-align:left;">
US-INF
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
AUCinf (<span class="math inline">\(\mu\)</span>g*h/mL)
</td>
<td style="text-align:left;">
38,703 <span class="math inline">\(\pm\)</span> 11,114
</td>
<td style="text-align:left;">
39,360 <span class="math inline">\(\pm\)</span> 12,332
</td>
<td style="text-align:left;">
39,270 <span class="math inline">\(\pm\)</span> 10,064
</td>
</tr>
<tr>
<td style="text-align:left;">
AUClast (<span class="math inline">\(\mu\)</span>g*h/mL)
</td>
<td style="text-align:left;">
36,862 <span class="math inline">\(\pm\)</span> 9133
</td>
<td style="text-align:left;">
37,022 <span class="math inline">\(\pm\)</span> 9398
</td>
<td style="text-align:left;">
37,368 <span class="math inline">\(\pm\)</span> 8332
</td>
</tr>
<tr>
<td style="text-align:left;">
Cmax (<span class="math inline">\(\mu\)</span>g/mL)
</td>
<td style="text-align:left;">
127.0 <span class="math inline">\(\pm\)</span> 16.9
</td>
<td style="text-align:left;">
126.2 <span class="math inline">\(\pm\)</span> 17.9
</td>
<td style="text-align:left;">
129.2 <span class="math inline">\(\pm\)</span> 18.8
</td>
</tr>
</tbody>
</table>
</div>
<div id="input-data" class="section level1">
<h1>Input Data</h1>
<p>As in <a href="sampleSize_parallel_2A3E.html">this vignette</a>, the
following inputs are required:</p>
<ul>
<li>Means for each endpoint and treatment arm
(<code>mu_list</code>),</li>
<li>Standard deviations for each endpoint and arm
(<code>sigma_list</code>),</li>
<li>Endpoint and arm names (<code>yname_list</code> and
<code>arm_names</code>),</li>
<li>Arms to be compared within each comparator
(<code>list_comparator</code>),</li>
<li>Endpoints to be compared within each comparator
(<code>list_y_comparator</code>).</li>
</ul>
<p>In this example, we simultaneously compare the trial drug (SB2) to
each reference biosimilar:</p>
<ul>
<li>SB2 vs. EU-INF</li>
<li>SB2 vs. US-INF</li>
</ul>
<p>We define the required list objects:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="co"># Mean values for each endpoint and arm</span></span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a>mu_list <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a>  <span class="at">SB2 =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">38703</span>, <span class="at">AUClast =</span> <span class="dv">36862</span>, <span class="at">Cmax =</span> <span class="fl">127.0</span>),</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a>  <span class="at">EUINF =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">39360</span>, <span class="at">AUClast =</span> <span class="dv">37022</span>, <span class="at">Cmax =</span> <span class="fl">126.2</span>),</span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a>  <span class="at">USINF =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">39270</span>, <span class="at">AUClast =</span> <span class="dv">37368</span>, <span class="at">Cmax =</span> <span class="fl">129.2</span>)</span>
<span id="cb1-6"><a href="#cb1-6" tabindex="-1"></a>)</span>
<span id="cb1-7"><a href="#cb1-7" tabindex="-1"></a></span>
<span id="cb1-8"><a href="#cb1-8" tabindex="-1"></a><span class="co"># Standard deviation values for each endpoint and arm</span></span>
<span id="cb1-9"><a href="#cb1-9" tabindex="-1"></a>sigma_list <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb1-10"><a href="#cb1-10" tabindex="-1"></a>  <span class="at">SB2 =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">11114</span>, <span class="at">AUClast =</span> <span class="dv">9133</span>, <span class="at">Cmax =</span> <span class="fl">16.9</span>),</span>
<span id="cb1-11"><a href="#cb1-11" tabindex="-1"></a>  <span class="at">EUINF =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">12332</span>, <span class="at">AUClast =</span> <span class="dv">9398</span>, <span class="at">Cmax =</span> <span class="fl">17.9</span>),</span>
<span id="cb1-12"><a href="#cb1-12" tabindex="-1"></a>  <span class="at">USINF =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="dv">10064</span>, <span class="at">AUClast =</span> <span class="dv">8332</span>, <span class="at">Cmax =</span> <span class="fl">18.8</span>)</span>
<span id="cb1-13"><a href="#cb1-13" tabindex="-1"></a>)</span></code></pre></div>
</div>
<div id="simultaneous-testing-of-independent-co-primary-endpoints" class="section level1">
<h1>Simultaneous Testing of Independent Co-Primary Endpoints</h1>
<p>In this analysis, we adopt the <strong>Ratio of Means (ROM)</strong>
approach to evaluate bioequivalence across independent co-primary
endpoints.</p>
<div id="different-hypotheses-across-endpoints" class="section level2">
<h2>Different Hypotheses across endpoints</h2>
<p>In this example, we aim to demonstrate:</p>
<ul>
<li>Bioequivalence of SB2 vs. EU-INF for AUCinf and Cmax, and</li>
<li>Bioequivalence of SB2 vs. US-INF for AUClast and Cmax.</li>
</ul>
<p>The comparisons are specified as follows:</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a><span class="co"># Arms to be compared</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>list_comparator <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>  <span class="at">EMA =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>, <span class="st">&quot;EUINF&quot;</span>),</span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>  <span class="at">FDA =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>, <span class="st">&quot;USINF&quot;</span>)</span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>)</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a></span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a><span class="co"># Endpoints to be compared</span></span>
<span id="cb2-8"><a href="#cb2-8" tabindex="-1"></a>list_y_comparator <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb2-9"><a href="#cb2-9" tabindex="-1"></a>  <span class="at">EMA =</span> <span class="fu">c</span>(<span class="st">&quot;AUCinf&quot;</span>, <span class="st">&quot;Cmax&quot;</span>),</span>
<span id="cb2-10"><a href="#cb2-10" tabindex="-1"></a>  <span class="at">FDA =</span> <span class="fu">c</span>(<span class="st">&quot;AUClast&quot;</span>, <span class="st">&quot;Cmax&quot;</span>)</span>
<span id="cb2-11"><a href="#cb2-11" tabindex="-1"></a>)</span></code></pre></div>
<p>For all endpoints, bioequivalence is established if the 90%
confidence intervals for the ratios of the geometric means fall within
the equivalence range of 80.00% to 125.00%.</p>
<p>Below we define the equivalence boundaries for each comparison:</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a>list_lequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>  <span class="st">&quot;EMA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">0.8</span>, <span class="at">Cmax =</span> <span class="fl">0.8</span>),</span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a>  <span class="st">&quot;FDA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="at">AUClast =</span> <span class="fl">0.8</span>, <span class="at">Cmax =</span> <span class="fl">0.8</span>)</span>
<span id="cb3-4"><a href="#cb3-4" tabindex="-1"></a>)</span>
<span id="cb3-5"><a href="#cb3-5" tabindex="-1"></a></span>
<span id="cb3-6"><a href="#cb3-6" tabindex="-1"></a>list_uequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb3-7"><a href="#cb3-7" tabindex="-1"></a>  <span class="st">&quot;EMA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">1.25</span>, <span class="at">Cmax =</span> <span class="fl">1.25</span>),</span>
<span id="cb3-8"><a href="#cb3-8" tabindex="-1"></a>  <span class="st">&quot;FDA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="at">AUClast =</span> <span class="fl">1.25</span>, <span class="at">Cmax =</span> <span class="fl">1.25</span>)</span>
<span id="cb3-9"><a href="#cb3-9" tabindex="-1"></a>)</span></code></pre></div>
<p>Here, the <code>list_comparator</code> parameter specifies the arms
being compared, while <code>list_lequi.tol</code> and
<code>list_uequi.tol</code> define the lower and upper equivalence
boundaries for the two endpoints.</p>
<p>To calculate the required sample size for testing equivalence under
the specified conditions, we use the <a href="../reference/sampleSize.html">sampleSize()</a> function. This
function computes the total sample size needed to achieve the target
power while ensuring equivalence criteria are met.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="fu">library</span>(SimTOST)</span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a></span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>(N_ss <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(<span class="at">power =</span> <span class="fl">0.9</span>,        <span class="co"># Target power</span></span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a>                    <span class="at">alpha =</span> <span class="fl">0.05</span>,      <span class="co"># Type I error rate</span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a>                    <span class="at">mu_list =</span> mu_list, <span class="co"># Means for each endpoint and arm</span></span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a>                    <span class="at">sigma_list =</span> sigma_list, <span class="co"># Standard deviations</span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a>                    <span class="at">list_comparator =</span> list_comparator, <span class="co"># Comparator arms</span></span>
<span id="cb4-8"><a href="#cb4-8" tabindex="-1"></a>                    <span class="at">list_y_comparator =</span> list_y_comparator, <span class="co"># Endpoints to compare</span></span>
<span id="cb4-9"><a href="#cb4-9" tabindex="-1"></a>                    <span class="at">list_lequi.tol =</span> list_lequi.tol, <span class="co"># Lower equivalence boundaries</span></span>
<span id="cb4-10"><a href="#cb4-10" tabindex="-1"></a>                    <span class="at">list_uequi.tol =</span> list_uequi.tol, <span class="co"># Upper equivalence boundaries</span></span>
<span id="cb4-11"><a href="#cb4-11" tabindex="-1"></a>                    <span class="at">dtype =</span> <span class="st">&quot;parallel&quot;</span>, <span class="co"># Trial design type</span></span>
<span id="cb4-12"><a href="#cb4-12" tabindex="-1"></a>                    <span class="at">ctype =</span> <span class="st">&quot;ROM&quot;</span>,      <span class="co"># Test type: Ratio of Means</span></span>
<span id="cb4-13"><a href="#cb4-13" tabindex="-1"></a>                    <span class="at">vareq =</span> <span class="cn">TRUE</span>,       <span class="co"># Assume equal variances</span></span>
<span id="cb4-14"><a href="#cb4-14" tabindex="-1"></a>                    <span class="at">lognorm =</span> <span class="cn">TRUE</span>,     <span class="co"># Log-normal distribution assumption</span></span>
<span id="cb4-15"><a href="#cb4-15" tabindex="-1"></a>                    <span class="at">nsim =</span> <span class="dv">1000</span>,        <span class="co"># Number of stochastic simulations</span></span>
<span id="cb4-16"><a href="#cb4-16" tabindex="-1"></a>                    <span class="at">seed =</span> <span class="dv">1234</span>))       <span class="co"># Random seed for reproducibility</span></span>
<span id="cb4-17"><a href="#cb4-17" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb4-18"><a href="#cb4-18" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb4-19"><a href="#cb4-19" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb4-20"><a href="#cb4-20" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-21"><a href="#cb4-21" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb4-22"><a href="#cb4-22" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. EUINF </span></span>
<span id="cb4-23"><a href="#cb4-23" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, Cmax </span></span>
<span id="cb4-24"><a href="#cb4-24" tabindex="-1"></a><span class="co">#&gt;       (multiple co-primary endpoints, m =  2 )</span></span>
<span id="cb4-25"><a href="#cb4-25" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. USINF </span></span>
<span id="cb4-26"><a href="#cb4-26" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUClast, Cmax </span></span>
<span id="cb4-27"><a href="#cb4-27" tabindex="-1"></a><span class="co">#&gt;       (multiple co-primary endpoints, m =  2 )</span></span>
<span id="cb4-28"><a href="#cb4-28" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb4-29"><a href="#cb4-29" tabindex="-1"></a><span class="co">#&gt;                  Parameter       Value</span></span>
<span id="cb4-30"><a href="#cb4-30" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size         117</span></span>
<span id="cb4-31"><a href="#cb4-31" tabindex="-1"></a><span class="co">#&gt;             Achieved Power          90</span></span>
<span id="cb4-32"><a href="#cb4-32" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 87.9 - 91.8</span></span>
<span id="cb4-33"><a href="#cb4-33" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
<p>A total sample size of 117 patients (or 39 per arm) is required to
demonstrate equivalence.</p>
</div>
</div>
<div id="simultaneous-testing-of-independent-primary-endpoints" class="section level1">
<h1>Simultaneous Testing of Independent Primary Endpoints</h1>
<div id="equivalence-for-at-least-2-of-the-3-endpoints-with-bonferroni-adjustment" class="section level2">
<h2>Equivalence for At Least 2 of the 3 Endpoints with Bonferroni
Adjustment</h2>
<p>In this example, we aim to establish equivalence for at least two out
of three primary endpoints while accounting for multiplicity using the
Bonferroni adjustment. The following assumptions are made:</p>
<ul>
<li>Equality of Variances: variances are assumed to be equal across
groups (<code>vareq = TRUE</code>).</li>
<li>Testing Parameter: the Ratio of Means (ROM) is used as the testing
parameter (<code>ctype = &quot;ROM&quot;</code>).</li>
<li>Design: a parallel trial design is assumed
(<code>dtype = &quot;parallel&quot;</code>).</li>
<li>Distribution: endpoint data follows a log-normal distribution
(<code>lognorm = TRUE</code>).</li>
<li>Correlation: endpoints are assumed to be independent, with no
correlation between them (default <code>rho = 0</code>).</li>
<li>Multiplicity Adjustment: the Bonferroni correction is applied to
control for Type I error (<code>adjust = &quot;bon&quot;</code>).</li>
<li>Equivalence Criterion: equivalence is required for at least two of
the three endpoints (<code>k = 2</code>).</li>
</ul>
<p>The comparisons and equivalence boundaries are defined as
follows:</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a><span class="co"># Endpoints to be compared for each comparator</span></span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a>list_y_comparator <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a>  <span class="at">EMA =</span> <span class="fu">c</span>(<span class="st">&quot;AUCinf&quot;</span>, <span class="st">&quot;AUClast&quot;</span>, <span class="st">&quot;Cmax&quot;</span>),</span>
<span id="cb5-4"><a href="#cb5-4" tabindex="-1"></a>  <span class="at">FDA =</span> <span class="fu">c</span>(<span class="st">&quot;AUCinf&quot;</span>, <span class="st">&quot;AUClast&quot;</span>, <span class="st">&quot;Cmax&quot;</span>)</span>
<span id="cb5-5"><a href="#cb5-5" tabindex="-1"></a>)</span>
<span id="cb5-6"><a href="#cb5-6" tabindex="-1"></a></span>
<span id="cb5-7"><a href="#cb5-7" tabindex="-1"></a><span class="co"># Define lower equivalence boundaries for each comparator</span></span>
<span id="cb5-8"><a href="#cb5-8" tabindex="-1"></a>list_lequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb5-9"><a href="#cb5-9" tabindex="-1"></a>  <span class="at">EMA =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">0.8</span>, <span class="at">AUClast =</span> <span class="fl">0.8</span>, <span class="at">Cmax =</span> <span class="fl">0.8</span>),</span>
<span id="cb5-10"><a href="#cb5-10" tabindex="-1"></a>  <span class="at">FDA =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">0.8</span>, <span class="at">AUClast =</span> <span class="fl">0.8</span>, <span class="at">Cmax =</span> <span class="fl">0.8</span>)</span>
<span id="cb5-11"><a href="#cb5-11" tabindex="-1"></a>)</span>
<span id="cb5-12"><a href="#cb5-12" tabindex="-1"></a></span>
<span id="cb5-13"><a href="#cb5-13" tabindex="-1"></a><span class="co"># Define upper equivalence boundaries for each comparator</span></span>
<span id="cb5-14"><a href="#cb5-14" tabindex="-1"></a>list_uequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb5-15"><a href="#cb5-15" tabindex="-1"></a>  <span class="at">EMA =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">1.25</span>, <span class="at">AUClast =</span> <span class="fl">1.25</span>, <span class="at">Cmax =</span> <span class="fl">1.25</span>),</span>
<span id="cb5-16"><a href="#cb5-16" tabindex="-1"></a>  <span class="at">FDA =</span> <span class="fu">c</span>(<span class="at">AUCinf =</span> <span class="fl">1.25</span>, <span class="at">AUClast =</span> <span class="fl">1.25</span>, <span class="at">Cmax =</span> <span class="fl">1.25</span>)</span>
<span id="cb5-17"><a href="#cb5-17" tabindex="-1"></a>)</span></code></pre></div>
<p>Finally, we calculate the required sample size:</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a>(N_mp <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(<span class="at">power =</span> <span class="fl">0.9</span>,       <span class="co"># Target power</span></span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a>                    <span class="at">alpha =</span> <span class="fl">0.05</span>,      <span class="co"># Type I error rate</span></span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a>                    <span class="at">mu_list =</span> mu_list, <span class="co"># Means for each endpoint and arm</span></span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a>                    <span class="at">sigma_list =</span> sigma_list, <span class="co"># Standard deviations</span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a>                    <span class="at">list_comparator =</span> list_comparator, <span class="co"># Comparator arms</span></span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a>                    <span class="at">list_y_comparator =</span> list_y_comparator, <span class="co"># Endpoints to compare</span></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a>                    <span class="at">list_lequi.tol =</span> list_lequi.tol, <span class="co"># Lower equivalence boundaries</span></span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a>                    <span class="at">list_uequi.tol =</span> list_uequi.tol, <span class="co"># Upper equivalence boundaries</span></span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a>                    <span class="at">k =</span> <span class="dv">2</span>,              <span class="co"># Number of endpoints required to demonstrate equivalence</span></span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a>                    <span class="at">adjust =</span> <span class="st">&quot;bon&quot;</span>,     <span class="co"># Bonferroni adjustment for multiple comparisons</span></span>
<span id="cb6-11"><a href="#cb6-11" tabindex="-1"></a>                    <span class="at">dtype =</span> <span class="st">&quot;parallel&quot;</span>, <span class="co"># Trial design type (parallel group)</span></span>
<span id="cb6-12"><a href="#cb6-12" tabindex="-1"></a>                    <span class="at">ctype =</span> <span class="st">&quot;ROM&quot;</span>,      <span class="co"># Test type: Ratio of Means</span></span>
<span id="cb6-13"><a href="#cb6-13" tabindex="-1"></a>                    <span class="at">vareq =</span> <span class="cn">TRUE</span>,       <span class="co"># Assume equal variances across arms</span></span>
<span id="cb6-14"><a href="#cb6-14" tabindex="-1"></a>                    <span class="at">lognorm =</span> <span class="cn">TRUE</span>,     <span class="co"># Log-normal distribution assumption</span></span>
<span id="cb6-15"><a href="#cb6-15" tabindex="-1"></a>                    <span class="at">nsim =</span> <span class="dv">1000</span>,        <span class="co"># Number of stochastic simulations</span></span>
<span id="cb6-16"><a href="#cb6-16" tabindex="-1"></a>                    <span class="at">seed =</span> <span class="dv">1234</span>))       <span class="co"># Random seed for reproducibility</span></span>
<span id="cb6-17"><a href="#cb6-17" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb6-18"><a href="#cb6-18" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb6-19"><a href="#cb6-19" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb6-20"><a href="#cb6-20" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-21"><a href="#cb6-21" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb6-22"><a href="#cb6-22" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. EUINF </span></span>
<span id="cb6-23"><a href="#cb6-23" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb6-24"><a href="#cb6-24" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb6-25"><a href="#cb6-25" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb6-26"><a href="#cb6-26" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb6-27"><a href="#cb6-27" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-28"><a href="#cb6-28" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. USINF </span></span>
<span id="cb6-29"><a href="#cb6-29" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb6-30"><a href="#cb6-30" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb6-31"><a href="#cb6-31" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb6-32"><a href="#cb6-32" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb6-33"><a href="#cb6-33" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-34"><a href="#cb6-34" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb6-35"><a href="#cb6-35" tabindex="-1"></a><span class="co">#&gt;                  Parameter       Value</span></span>
<span id="cb6-36"><a href="#cb6-36" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size          93</span></span>
<span id="cb6-37"><a href="#cb6-37" tabindex="-1"></a><span class="co">#&gt;             Achieved Power          90</span></span>
<span id="cb6-38"><a href="#cb6-38" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 87.9 - 91.8</span></span>
<span id="cb6-39"><a href="#cb6-39" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
</div>
<div id="unequal-allocation-rates-across-arms" class="section level2">
<h2>Unequal Allocation Rates Across Arms</h2>
<p>In this example, we build upon the previous scenario but introduce
unequal allocation rates across treatment arms. Specifically, we require
that the number of patients in the new treatment arm is double the
number in each of the reference arms.</p>
<p>This can be achieved by specifying the treatment allocation rate
parameter (<code>TAR</code>). Rates are provided as a vector, for
example: <code>TAR = c(2, 1, 1)</code>. This ensures that for every two
patients assigned to the new treatment arm, one patient is assigned to
each reference arm.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a>(N_mp2 <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(<span class="at">power =</span> <span class="fl">0.9</span>,       <span class="co"># Target power</span></span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a>                     <span class="at">alpha =</span> <span class="fl">0.05</span>,      <span class="co"># Type I error rate</span></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a>                     <span class="at">mu_list =</span> mu_list, <span class="co"># Means for each endpoint and arm</span></span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a>                     <span class="at">sigma_list =</span> sigma_list, <span class="co"># Standard deviations</span></span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a>                     <span class="at">list_comparator =</span> list_comparator, <span class="co"># Comparator arms</span></span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a>                     <span class="at">list_y_comparator =</span> list_y_comparator, <span class="co"># Endpoints to compare</span></span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a>                     <span class="at">list_lequi.tol =</span> list_lequi.tol, <span class="co"># Lower equivalence boundaries</span></span>
<span id="cb7-8"><a href="#cb7-8" tabindex="-1"></a>                     <span class="at">list_uequi.tol =</span> list_uequi.tol, <span class="co"># Upper equivalence boundaries</span></span>
<span id="cb7-9"><a href="#cb7-9" tabindex="-1"></a>                     <span class="at">k =</span> <span class="dv">2</span>,              <span class="co"># Number of endpoints required to demonstrate equivalence</span></span>
<span id="cb7-10"><a href="#cb7-10" tabindex="-1"></a>                     <span class="at">adjust =</span> <span class="st">&quot;bon&quot;</span>,     <span class="co"># Bonferroni adjustment for multiple comparisons</span></span>
<span id="cb7-11"><a href="#cb7-11" tabindex="-1"></a>                     <span class="at">TAR =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span> <span class="ot">=</span> <span class="dv">2</span>, <span class="st">&quot;EUINF&quot;</span> <span class="ot">=</span> <span class="dv">1</span>, <span class="st">&quot;USINF&quot;</span> <span class="ot">=</span> <span class="dv">1</span>), <span class="co"># Treatment allocation rates</span></span>
<span id="cb7-12"><a href="#cb7-12" tabindex="-1"></a>                     <span class="at">dtype =</span> <span class="st">&quot;parallel&quot;</span>, <span class="co"># Trial design type (parallel group)</span></span>
<span id="cb7-13"><a href="#cb7-13" tabindex="-1"></a>                     <span class="at">ctype =</span> <span class="st">&quot;ROM&quot;</span>,      <span class="co"># Test type: Ratio of Means</span></span>
<span id="cb7-14"><a href="#cb7-14" tabindex="-1"></a>                     <span class="at">vareq =</span> <span class="cn">TRUE</span>,       <span class="co"># Assume equal variances across arms</span></span>
<span id="cb7-15"><a href="#cb7-15" tabindex="-1"></a>                     <span class="at">lognorm =</span> <span class="cn">TRUE</span>,     <span class="co"># Log-normal distribution assumption</span></span>
<span id="cb7-16"><a href="#cb7-16" tabindex="-1"></a>                     <span class="at">nsim =</span> <span class="dv">1000</span>,        <span class="co"># Number of stochastic simulations</span></span>
<span id="cb7-17"><a href="#cb7-17" tabindex="-1"></a>                     <span class="at">seed =</span> <span class="dv">1234</span>))       <span class="co"># Random seed for reproducibility</span></span>
<span id="cb7-18"><a href="#cb7-18" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb7-19"><a href="#cb7-19" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb7-20"><a href="#cb7-20" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb7-21"><a href="#cb7-21" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-22"><a href="#cb7-22" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb7-23"><a href="#cb7-23" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. EUINF </span></span>
<span id="cb7-24"><a href="#cb7-24" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb7-25"><a href="#cb7-25" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb7-26"><a href="#cb7-26" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb7-27"><a href="#cb7-27" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb7-28"><a href="#cb7-28" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-29"><a href="#cb7-29" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. USINF </span></span>
<span id="cb7-30"><a href="#cb7-30" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb7-31"><a href="#cb7-31" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb7-32"><a href="#cb7-32" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb7-33"><a href="#cb7-33" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb7-34"><a href="#cb7-34" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-35"><a href="#cb7-35" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb7-36"><a href="#cb7-36" tabindex="-1"></a><span class="co">#&gt;                  Parameter       Value</span></span>
<span id="cb7-37"><a href="#cb7-37" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size          96</span></span>
<span id="cb7-38"><a href="#cb7-38" tabindex="-1"></a><span class="co">#&gt;             Achieved Power          90</span></span>
<span id="cb7-39"><a href="#cb7-39" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 87.9 - 91.8</span></span>
<span id="cb7-40"><a href="#cb7-40" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
<p>Results indicate that 48 patients are required for the active
treatment arm (SB2), and 24 patients are required for each reference
arm. The total sample size required is 96, which is larger compared to
the trial with an equal allocation ratio, for which the total sample
size was 93.</p>
</div>
<div id="accounting-for-participant-dropout" class="section level2">
<h2>Accounting for Participant Dropout</h2>
<p>In the examples above, the sample size calculations assumed that all
enrolled patients complete the trial. However, in practice, a certain
percentage of participants drop out, which can impact the required
sample size. To account for this, we consider a 20% dropout rate across
all treatment arms.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a>(N_mp3 <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(<span class="at">power =</span> <span class="fl">0.9</span>,       <span class="co"># Target power</span></span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>                     <span class="at">alpha =</span> <span class="fl">0.05</span>,      <span class="co"># Type I error rate</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a>                     <span class="at">mu_list =</span> mu_list, <span class="co"># Means for each endpoint and arm</span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a>                     <span class="at">sigma_list =</span> sigma_list, <span class="co"># Standard deviations</span></span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>                     <span class="at">list_comparator =</span> list_comparator, <span class="co"># Comparator arms</span></span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>                     <span class="at">list_y_comparator =</span> list_y_comparator, <span class="co"># Endpoints to compare</span></span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a>                     <span class="at">list_lequi.tol =</span> list_lequi.tol, <span class="co"># Lower equivalence boundaries</span></span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a>                     <span class="at">list_uequi.tol =</span> list_uequi.tol, <span class="co"># Upper equivalence boundaries</span></span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a>                     <span class="at">k =</span> <span class="dv">2</span>,              <span class="co"># Number of endpoints required to demonstrate equivalence</span></span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a>                     <span class="at">adjust =</span> <span class="st">&quot;bon&quot;</span>,     <span class="co"># Bonferroni adjustment for multiple comparisons</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a>                     <span class="at">TAR =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span> <span class="ot">=</span> <span class="dv">2</span>, <span class="st">&quot;EUINF&quot;</span> <span class="ot">=</span> <span class="dv">1</span>, <span class="st">&quot;USINF&quot;</span> <span class="ot">=</span> <span class="dv">1</span>), <span class="co"># Treatment allocation rates</span></span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a>                     <span class="at">dropout =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span> <span class="ot">=</span> <span class="fl">0.20</span>, <span class="st">&quot;EUINF&quot;</span> <span class="ot">=</span> <span class="fl">0.20</span>, <span class="st">&quot;USINF&quot;</span> <span class="ot">=</span> <span class="fl">0.20</span>), <span class="co"># Expected dropout rates</span></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a>                     <span class="at">dtype =</span> <span class="st">&quot;parallel&quot;</span>, <span class="co"># Trial design type (parallel group)</span></span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a>                     <span class="at">ctype =</span> <span class="st">&quot;ROM&quot;</span>,      <span class="co"># Test type: Ratio of Means</span></span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a>                     <span class="at">vareq =</span> <span class="cn">TRUE</span>,       <span class="co"># Assume equal variances across arms</span></span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a>                     <span class="at">lognorm =</span> <span class="cn">TRUE</span>,     <span class="co"># Log-normal distribution assumption</span></span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a>                     <span class="at">nsim =</span> <span class="dv">1000</span>,        <span class="co"># Number of stochastic simulations</span></span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a>                     <span class="at">seed =</span> <span class="dv">1234</span>))       <span class="co"># Random seed for reproducibility</span></span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. EUINF </span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb8-29"><a href="#cb8-29" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-30"><a href="#cb8-30" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. USINF </span></span>
<span id="cb8-31"><a href="#cb8-31" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: AUCinf, AUClast, Cmax </span></span>
<span id="cb8-32"><a href="#cb8-32" tabindex="-1"></a><span class="co">#&gt;       (multiple primary endpoints, k =  2 )</span></span>
<span id="cb8-33"><a href="#cb8-33" tabindex="-1"></a><span class="co">#&gt;     - Multiplicity Correction: Bonferroni </span></span>
<span id="cb8-34"><a href="#cb8-34" tabindex="-1"></a><span class="co">#&gt;       Adjusted Significance Levels: alpha = 0.0167 </span></span>
<span id="cb8-35"><a href="#cb8-35" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-36"><a href="#cb8-36" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb8-37"><a href="#cb8-37" tabindex="-1"></a><span class="co">#&gt;                  Parameter       Value</span></span>
<span id="cb8-38"><a href="#cb8-38" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size         120</span></span>
<span id="cb8-39"><a href="#cb8-39" tabindex="-1"></a><span class="co">#&gt;             Achieved Power          90</span></span>
<span id="cb8-40"><a href="#cb8-40" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 87.9 - 91.8</span></span>
<span id="cb8-41"><a href="#cb8-41" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
<p>Considering a 20% dropout rate, the total sample size required is
120.</p>
</div>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="unnumbered">References</h1>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-shin_randomized_2015" class="csl-entry">
Shin, Donghoon, Youngdoe Kim, Yoo Seok Kim, Thomas Körnicke, and Rainard
Fuhr. 2015. <span>“A <span>Randomized</span>, <span>Phase I
Pharmacokinetic Study Comparing SB2</span> and <span>Infliximab
Reference Product</span> (<span>Remicade</span><span></span>) in
<span>Healthy Subjects</span>.”</span> <em>BioDrugs</em> 29 (6): 381–88.
<a href="https://doi.org/10.1007/s40259-015-0150-5">https://doi.org/10.1007/s40259-015-0150-5</a>.
</div>
<div id="ref-sozu_sample_2015" class="csl-entry">
Sozu, Takashi, Tomoyuki Sugimoto, Toshimitsu Hamasaki, and Scott R.
Evans. 2015. <em>Sample <span>Size Determination</span> in
<span>Clinical Trials</span> with <span>Multiple Endpoints</span></em>.
<span>SpringerBriefs</span> in <span>Statistics</span>. Cham: Springer
International Publishing. <a href="https://doi.org/10.1007/978-3-319-22005-5">https://doi.org/10.1007/978-3-319-22005-5</a>.
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
